Combined Antiplatelets and Anticoagulants for Atherosclerosis: Insights from the COMPASS Study
Kelley Branch, MD, MS, and Jeffery Probstfield, MD, provide insight into the COMPASS study, discussing the objectives and primary outcomes, proven effective secondary prevention therapies and conclusions from the study.
Created by
Related Presenters
Director of Cardiovascular Clinical Trials at the University of Washington, Seattle Associate Director of the Clinical Trials Service Unit
Kelley Robert Branch, M.D., M.S., is an associate professor in the UW Division of Cardiology. He is also the director of Cardiovascular Clinical Trials at the UW and associate director of the Clinical Trials Service Unit that facilitates ...
Jeffrey Probstfield, MD, FACP, FACC, FESC
Professor of Medicine, Adjunct Professor of Epidemiology, School of Public Health Director, Clinical Trials Service Unit
In 1995, the Clinical Trials Service Unit (CTSU) in the Division of Cardiology was founded by the current CTSU Director, Jeffrey Probstfield, M.D. Dr. Probstfield brought his years of experience in clinical trials training to direct the ...